Head-to-head for women
Hers vs Ro
Hers and Ro both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Metabolic-Fit Score — our women's-health rubric.
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Hers
Metabolic-Fit 63/100 · Grade C
Metabolic-Fit / 100
Best for: Mothers who want a familiar, app-driven consumer brand and are comfortable budgeting for a separate membership fee on top of the posted medication price.
Visit HersRo
Higher scoreMetabolic-Fit 84/100 · Grade B
Metabolic-Fit / 100
Best for: Mothers who specifically want an FDA-approved, on-label medication and help getting it covered, and are comfortable on a large consumer platform, budgeting membership and medication as separate line items.
Visit RoThe verdict for women
Ro edges out Hers on the Metabolic-Fit Score, 84 to 63 (B vs C). Mothers who specifically want an FDA-approved, on-label medication and help getting it covered, and are comfortable on a large consumer platform, budgeting membership and medication as separate line items.
Hers is still a genuine option — an FDA warning letter dated September 2025, over the compounded-semaglutide business it has since left behind. One of the few mass-market brands designed around a woman's front door — now selling FDA-approved brand Wegovy and Zepbound instead of the compounded semaglutide it used to, though the posted price is only half the bill once the required $149/mo membership is added. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
Price highlights compare average monthly budgets, using 52 weeks ÷ 12 months for weekly cycles. Quoted charges retain their billing units; unknown periods and fee-only or prepaid quotes do not compete.
| Detail | Hers | Ro |
|---|---|---|
| Metabolic-Fit Score | 63/100 · C | 84/100 · B |
| Overall rank | #33 | #4 |
| Semaglutide | $149/mo Wegovy Pill + $149/mo membership (~$298/mo all-in) | $149/mo membership month to month, $74/mo on annual prepay (medication billed separately) |
| Tirzepatide | $299/mo Zepbound + $149/mo membership (~$448/mo all-in) | $149/mo membership month to month, $74/mo on annual prepay (medication billed separately) |
| Coverage | Not available in all 50 states; no complete list published | Multi-state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
The decision beyond the score
Both routes separate membership from brand medication
Hers and Ro now offer brand-name weight medication rather than treating their public care fee as the whole prescription cost. Hers' ordinary membership is $149 monthly, with a $39 first month. Its starting medication amounts produce approximate ongoing totals of $298 for a Wegovy pill, $348 for a Wegovy pen and $448 for Zepbound. Medication prices can vary with dose. Ro also lists $149 monthly membership after a $39 first month, or as low as $74 monthly with annual prepayment, but does not establish one universal combined drug-and-care amount. Matching membership charges do not prove matching treatment bills.
Ro's annual membership equivalent should not be compared with Hers' ordinary membership without showing the upfront commitment. It also leaves medication to be paid separately. Ask both companies for the selected product, prescribed dose, pharmacy charge and next membership payment. If insurance is involved, obtain the expected cost sharing rather than treating a conditional copay as a cash quote. A first-month discount can make entry less expensive while the ongoing medication-and-membership total remains much larger. Budgeting for the next several refills is more useful than comparing the initial enrollment charge alone.
Women's positioning and insurance assistance are different benefits
Hers has an explicitly women-focused brand and an app offering oral and injectable brand options, subject to availability. That presentation does not establish dedicated postpartum or PCOS clinical care. Ro emphasizes insurance assistance through its concierge, which may be useful for an appropriate brand prescription, but does not guarantee an insurer's approval. A mother choosing between them should ask who will address her actual medical history, which follow-ups are expected and how an outside clinician can coordinate care. Neither branding nor administrative assistance substitutes for an appropriate prescribing decision.
Hers carries a September 2025 FDA warning letter relating to its previous compounded-semaglutide business. That history should remain visible while distinguishing it from the present brand-product menu. Both services require location-specific availability checks, and a brand prescription still carries the particular product's precautions, including questions about pregnancy planning or breastfeeding to discuss with a clinician. Hers may be relevant when its product menu and service fit your needs; Ro may be relevant when its insurance administration or membership arrangement is useful. The practical choice rests on the actual medicine and complete continuing bill, not on assuming that the same $149 care charge makes the two programs interchangeable.
Based on the public terms documented in the Hers review and Ro review. Each review details the prices and terms. Confirm current terms before paying.
Metabolic-Fit / 100
Hers
Metabolic-Fit 63/100 · Grade C
What we like
- Explicit women-focused positioning and a brand many mothers already trust
- Now selling FDA-approved brand-name medication (Wegovy, Zepbound) rather than compounded semaglutide
- An app with oral and injectable brand-name options; availability varies by state.
The caveats
- Carries an FDA warning letter dated September 2025 over the prior compounded-semaglutide business, before this pivot to brand-name product
- The posted 'from $149/mo' price is medication only — a required $149/mo membership (billed separately, $39 the first month) roughly doubles the real ongoing cost
- A general weight program, not a clinician-led metabolic service with postpartum or PCOS specialization
Metabolic-Fit / 100
Ro
Metabolic-Fit 84/100 · Grade B
What we like
- Access to brand-name Wegovy and Zepbound with a dedicated insurance concierge that files paperwork
- On-label products carry the manufacturer's own pregnancy and lactation language — cleaner to hand to an OB
- Fast cash-pay start — under a week to first dose, per Ro's own site
The caveats
- No compounded option — brand-name only, and cash-pay brand medication is expensive without coverage
- The membership fee and the medication cost are always separate charges; Ro doesn't publish a combined monthly
- Not disclosed whether monthly check-ins require a live video visit or run async
Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Comparisons close to Hers vs Ro.
- Hers vs Zealthy
- CoreAge Rx vs Ro
- Form Health vs Ro
- Form Health vs Hers
- CoreAge Rx vs Sesame
- CoreAge Rx vs Calibrate
Or browse the full comparison hub.